Innovation cooperation platform

Innovation

All categories

Popular information

CDMO

CDMO

Description:
Description:
Information

Viwit platform provides CDMO services of APIs and intermediates, oral solids (tablets, capsules), sterile liquid products (small volume injections-ampoules, small volume injections-vials, eye drops). The production facilities comply with the cGMP regulations of China's NMPA, US FDA and EU EMA.

The platform's existing CDMO resources include:

1. API facility that was succesfully audited by US FDA and Health Canada;

2. US FDA cGMP oral solids production facility that can produce tablets, capsules and other dosage forms;

3. Sterile injectables (ampoules) facility that was GMP certified by China NMPA;

4. Production workshops for injectables (vials) and opthalmic eye drops (unit-dose and multi-dose) are being built in accordance with FDA standards

The CDMO services currently available on the platform include:

1. R&D services

1) Contract R&D of FDFs: tablets and capsules (IR/ER/DR), injections, eye drops, nano/microsphere products;

2) Contract R&D of APIs: chemically synthesized APIs or semi-synthetic APIs;

3) Contract R&D of intermediates for innovative medicines

2. Production services

1) Contract production of FDFs: tablets, capsules, oral powders, injections;

2) Contract production of APIs: chemically synthesized APIs or semi-synthetic APIs;

3) Contract production of pharmaceutical intermediates.

Scan the QR code to read on your phone

search
Confirm
Close